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Analysis of 113 hospitalized patients with confirmed 2009
influenza A (H1N1) virus infection
Esragül AKINCI1, Bircan KAYAASLAN1, Meltem Arzu YETKİN1, Sevim YILMAZ1, Işıl Deniz ALIRAVCI1,
Sümeyye YILDIZ1, Fatmanur ÜLGEN1, Selim Sırrı EREN1, Ayşe BUT1, Gülruhsar YILMAZ1, Oya KILCI2,
Nevzat Mehmet MUTLU2, Hatice YAĞMURDUR2, Hürrem BODUR1

Aim: To evaluate the demographic characteristics, clinical and laboratory features, underlying medical conditions,
treatment, and outcome of hospitalized patients with laboratory-confirmed infection due to the 2009 influenza A(H1N1)
virus.
Materials and methods: This prospective study was performed between October and December 2009. The hospitalized
patients with laboratory-confirmed diagnosis of 2009 influenza A(H1N1) virus infection were included in the study. The
diagnosis was confirmed with detection of the virus in nasal and nasopharyngeal swabs by RT-PCR assay. Demographic
and epidemiological characteristics, clinical features, treatment, and outcome of the patients were recorded on the
individual forms. A comparison was made between patients with and without pneumonia.
Results: From October to December 2009, 113 confirmed patients with 2009 influenza A(H1N1) virus infection were
hospitalized in our clinic. The ages of the patients were between 17 and 77 years (mean age 35.7 ± 15.8 years) and 73
(64.6%) were female. Cough (92.9%), fever (85.8%), malaise (85.8%), headache (80.5%), and muscle aches (85.0%) were
the most common presenting symptoms. The time from symptom onset to hospital admission was 1-15 days (mean
time 3.8 ± 3 days). On physical examination, fever (74.3%), pharyngeal hyperemia (66.4%), rales (43.4%), dyspnea
(29.2%), and cyanosis (4.4%) were the presenting clinical findings. Of the patients, 64 (56.6%) had at least 1 underlying
medical condition. The most common underlying disease was chronic pulmonary disease (14.5%). A total of 25 patients
were pregnant. On admission to hospital, 25 patients (22.1%) had leukopenia, 12 patients (10.6%) had leukocytosis,
and 29 patients (25.7%) had thrombocytopenia. Pulmonary infiltrates consistent with pneumonia were detected on
chest radiography in 47 (41.6%) patients.Of these patients, 98 (86.7%) received oseltamivir treatment on admission. Six
patients (5.3%) were admitted to the ICU because of acute respiratory failure and 4 of them (3.5%) required mechanical
ventilation. Among these patients, 3 (2.7%) died. A comparison between the patients with and without pneumonia
was performed statistically. Age older than 40 years old, time from onset of symptoms to admission longer than 3 days,
leukocytosis, ALT/AST elevation, and hyperglycemia were significantly higher in patients with pneumonia.
Conclusion: Although the 2009 influenza A(H1N1) virus causes severe illness including pneumonia and death, the
mortality rate is not very high. The characteristics of the disease are similar to those of seasonal influenza. Young adults
were the most affected persons and most of the patients had underlying medical conditions.
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2009 influenza A (H1N1) enfeksiyonu tanısıyla yatırılan 113 hastanın analizi
Amaç: Bu çalışmanın amacı, 2009 influenza A(H1N1) kesin tanısı konulan ve yatırılarak takip edilen hastaların
demografik özellikleri, klinik ve laboratuvar bulguları, altta yatan hastalıkları, tedavi ve prognozunu değerlendirmektir.
Yöntem ve gereç: Bu prospektif çalışma Ekim-Aralık 2009 tarihleri arasında yapıldı. 2009 influenza A(H1N1) tanısı
kesinleşmiş yatan hastalar çalışmaya alındı. Tanı, nazal ve nazofaringeal sürüntü örneklerinde RT-PCR ile virüs tespit
edilerek konuldu. Hastaların demografik ve epidemiyolojik özellikleri, klinik bulguları, tedavi ve prognozu hazırlanan
hasta formlarına kaydedildi. Pnömonisi olan ve olmayan hastalar arasında karşılaştırma yapıldı.
Bulgular: Ekim-Aralık 2009 arasında, 2009 influenza A(H1N1) enfeksiyonu tanısıyla 113 hasta kliniğimizde yatırılarak
takip edildi. Hastaların yaşları 17-77 (ortalama 35,7 ± 15,8) arasında değişmekte idi ve 73’ü (% 64,6) kadındı. En sık
görülen semptomlar, öksürük (% 92,9), ateş (% 85,8), halsizlik (% 85,8), baş ağrısı (% 80,5) ve kas ağrısı (% 85) idi.
Hastaneye yatışa kadar olan semptomların süresi 1-15 gün (ortalama 3,8 ± 3) arasında değişmekteydi. Fizik muayenede
ateş (% 74,3), faringeal hiperemi (% 66,4), ral (% 43,4), dispne (% 29,2) ve siyanoz (% 4,4) tespit edildi. Hastaların 64’ünde
(% 56,6) altta yatan en az bir hastalık vardı ve en sık tespit edilen kronik akciğer hastalığı (% 14,5) idi. Gebelik 25 hastada
mevcuttu. Yatışta 25 hastada (% 22,1) lökopeni, 12 hastada (% 10,6) lökositoz ve 29 hastada (% 25,7) trombositopeni
tespit edildi. Akciğer grafisinde pnömoni ile uyumlu infiltrasyonlar 47 (% 41,6) hastada saptandı. Oseltamivir 98 (%
86,7) hastaya verildi. Hastaların 6’sı (% 5,3) akut solunum yetmezliği nedeniyle yoğun bakım ünitesine kabul edildi ve
4’ü (% 3,5) mekanik ventilator bağlandı. Üç hasta (% 2,7) kaybedildi. Pnömonisi olan ve olmayan hastalar istatistiksel
olarak karşılaştırıldı. Yaşın 40’ın üzerinde olması, semptomların süresinin 3 günden fazla olması, lökositoz, ALT/AST
yüksekliği ve hiperglisemi, pnömonisi olanlarda anlamlı oranda yüksek bulundu.
Sonuç: 2009 influenza A(H1N1) enfeksiyonu, pnömoni ve ölüm gibi ciddi tablolara yol açsa da mortalite oranı çok
yüksek değildir. Hastalığın özellikleri mevsimsel influenza gibidir. Genç erişkinler en çok etkilenen kişilerdir ve çoğunda
altta yatan hastalık vardır.
Anahtar sözcükler: Influenza, H1N1, grip

Introduction
Human infection with the novel influenza A(H1N1)
virus was first reported in April 2009 in Mexico and
then it spread to the United States and other countries
in the world (1,2). On 11 June 2009 the World Health
Organization (WHO) raised the pandemic alert to
‘Phase 6’, which is the highest alert level (3).
The 2009 influenza A(H1N1) virus represents a
reassortment of human, avian, and swine influenza
viruses (4). The infection with 2009 influenza
A(H1N1) generally presents mild disease with
symptoms similar to those of seasonal influenza
A. Young adults are the most affected people. The
hospitalization rate is up to 10% among confirmed
cases. A significant proportion of hospitalized
patients have pneumonia. The presence of underlying
diseases poses a greater risk of death, and mortality
is below 1%. The most common causes of death are
pneumonia and acute respiratory distress syndrome
(ARDS) (5-7).
In this report, we describe the demographic
characteristics, clinical and laboratory features,
underlying medical conditions, treatment, and
outcome of hospitalized patients with laboratory508

confirmed infection due to the 2009 influenza
A(H1N1) virus.
Materials and methods
This prospective study was performed between
October and December 2009. The hospitalized
patients with laboratory-confirmed diagnosis of 2009
influenza A(H1N1) virus infection were included in
the study.
The patients admitted to our hospital with
symptoms of influenza-like illness (fever, sore throat,
or cough) were evaluated for hospitalization. On
admission, blood analyses were performed in all
patients and the non-pregnant ones underwent
chest radiography. Patients with underlying medical
conditions (pregnancy, obesity, chronic pulmonary
disease, cardiovascular diseases, malignancy,
diabetes mellitus etc.), pulmonary infiltrates on
chest radiography, or severe clinical presentation
were hospitalized. Severe cases were defined in
patients admitted to an intensive care unit (ICU),
requiring mechanical ventilation, presenting signs of
respiratory failure (tachypnea, cyanosis or hypoxia
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with oxygen saturation below 90%), or having severe
vomiting or hypotension (systolic blood pressure
below 90 mmHg). Nasal and nasopharyngeal swabs
were performed from all of the hospitalized patients
and only confirmed cases were included in the study.
The diagnosis was confirmed with detection
of 2009 influenza A(H1N1) virus in nasal and
nasopharyngeal swabs by real-time reversetranscriptase-polymerase-chain reaction (RT-PCR)
assay. All RT-PCR tests were performed at Refik
Saydam National Public Health Agency, Virology
Reference and Research Laboratory.
On admission, oseltamivir treatment was
recommended to all of the patients, including
pregnant women. Except for some pregnant women,
all of the patients agreed to receive it. Oseltamivir
was given for 5 days at a dose of 75 mg twice daily.
The patients with pulmonary infiltrates on chest
radiography, leukocytosis, or symptoms of acute
sinusitis or exacerbation of chronic obstructive
pulmonary disease (COPD) were given empirical
antibiotic treatment. Before initiation of antibiotics,
blood cultures were performed. Most of the patients
could not expectorate. Thus, sputum cultures were
done in very few patients. Oxygen saturations of
the patients were measured by pulse oxymetry
periodically from admission to discharge.
Demographic and epidemiological characteristics,
clinical features, laboratory and radiographic
findings, underlying medical conditions, treatment,
and outcome of the patients were recorded on the
individual forms. A comparison was made between
patients with and without pneumonia. Statistical
analyses were performed using SPSS v.16. For
categorical measures, Fisher’s exact test or Pearson’s
chi-square test was used; for continuous measures,
unpaired Student’s t test was used.
Results
Clinical characteristics
From October to December 2009, 113 confirmed
patients with 2009 influenza A(H1N1) virus infection
were hospitalized in our clinic and included in the
study. The ages of the patients were between 17 and
77 years (mean age 35.7 ± 15.8 years) and 73 (64.6%)
were female. Cough (92.9%), fever (85.8%), malaise

(85.8%), headache (80.5%), and muscle aches (85.0%)
were the most common presenting symptoms. The
time from symptom onset to hospital admission
was 1-15 days (mean time 3.8 ± 3 days) (Table 1).
Twenty-five patients (22.1%) had a history of contact
with 2009 influenza A(H1N1) virus infected persons.
None of the 113 patients had received swine flu
vaccine.
On physical examination, fever (74.3%),
pharyngeal hyperemia (66.4%), rales (43.4%),
dyspnea (29.2%), and cyanosis (4.4%) were the
presenting clinical findings (Table 2). Of the 113
hospitalized patients, 64 (56.6%) had at least 1
underlying medical condition and 15 (13.3%) had
2 such conditions. The most common underlying
disease was chronic pulmonary disease (14.5%). It was
followed by diabetes mellitus (Table 3). A total of 25
patients were pregnant, of whom 4 had an underlying
diseases (asthma in 1 patient, hypothyroidism in 2
patients, and diabetes mellitus in 1 patient).
Table 1. Demographic characteristics and symptoms of
hospitalized patients with confirmed 2009 influenza
A(H1N1) virus infection.

Characteristics
Age, years
Mean age
Age ≤ 40 years
Age > 40 years
Female gender

No. (%) of Patients
(n = 113)
35.7 ± 15.8 (17-77)
75 (66.4)
38 (33.6)
73 (64.6)

Contact with H1N1 infected patient

25 (22.1)

Time from onset to admission, days

3.8 ± 3 (1-15)

Cough

105 (92.9)

Fever

97 (85.8)

Malaise

97 (85.8)

Muscle aches

96 (85.0)

Headache

91 (80.5)

Sore throat

75 (66.4)

Nausea

66 (58.4)

Shortness of breath

59 (52.2)

Chills

53 (46.9)

Rhinorrhea

33 (29.2)

Vomiting

30 (26.5)

Diarrhea

10 (8.8)
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Table 2. Clinical and laboratory findings of hospitalized
patients with confirmed 2009 influenza A(H1N1) virus
infection.

Characteristics

No. (%) of
Patients
(n = 113)

Fever
Pharyngeal hyperemia
Rales on chest examination
Dyspnea
Cyanosis
Leukopenia (WBCa < 4400/mm3)
Leukocytosis (WBC > 11,300/mm3)
Neutrophilia (neutrophils > 74%)
Neutropenia (neutrophils < 45%)
Lymphocytosis (lymphocytes > 45%)
Lymphopenia (lymphocytes < 18%)
Monocytosis (monocytes > 13%)

84 (74.3)
75 (66.4)
49 (43.4)
33 (29.2)
5 (4.4)
25 (22.1)
12 (10.6)
54 (47.8)
11 (9.7)
6 (5.3)
60 (53.1)
16 (14.2)

Table 3. Underlying medical conditions of hospitalized patients
with confirmed 2009 influenza A(H1N1) virus
infection.

Underlying Medical Conditions
Pregnancya

25 (34.2)

Obesityb
Chronic pulmonary disease

No. (%) of Patients
(n = 113)
2 (1.8)

c

17 (14.5)

Diabetes mellitus

13 (11.5)

Hypertension

13 (11.5)

Cardiovascular diseased

6 (5.1)

Malignancy

4 (3.5)

Hypothyroidism

4 (3.5)

Others
Total

3 (2.7)
64 (56.6)

a

The ratio was calculated between the female patients.
Mean body mass index greater than 30.
c
Including asthma and COPD.
d
Including ischemic heart disease, congestive heart failure, and
arrhythmia.
b

Thrombocytopenia (thrombocytes
< 150,000/mm3)

29 (25.7)

Elevation of ALT/ASTb (>45 U/L)
Elevation of creatinine (>1.4 mg/dL)
Hyperglycemias (>115 mg/dL)

26 (23.0)
6 (5.3)
25 (22.1)

Hypoxia
c
SO2 < 90%
SO2 < 80%
Infiltration on chest radiography

24 (21.2)
13 (11.5)
47 (41.6)

Abbreviations: WBCa: White blood cell, ALT/ASTb: Alanine
aminotransferase/Aspartate aminotransferase, cSO2: Oxygen
saturation

Laboratory findings
On admission to hospital, 76 patients (67.3%)
had white blood cell (WBC) counts in normal
ranges, 25 patients (22.1%) had leukopenia, 12
patients (10.6%) had leukocytosis, and 29 patients
(25.7%) had thrombocytopenia. Leukocyte formulas
revealed neutrophilia in 47.7% and lymphopenia
in 53.1% of the patients. Biochemical test results
showed hyperglycemias (5.3%), and elevated ALT/
AST (23%) and creatinine (5.3%) levels. Pulmonary
infiltrates consistent with pneumonia were detected
on chest radiography in 47 (41.6%) patients. Oxygen
saturation was below 90% in 24 patients (21.2%)
(Table 2). All culture results (blood, sputum, urine
etc.) were negative.
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Treatment
Of the 113 patients, 98 (86.7%) received
oseltamivir treatment on admission (Table 4). Fifteen
patients (13.3%) refused to receive oseltamivir
because of pregnancy. Oseltamivir treatment was
started within 48 h of the onset of symptoms in
45.1% of the patients. The other patients received
oseltamivir after 48 h from the onset of symptoms
because of late admission to the hospital. In 73
patients (64.6%), antibiotic treatment was initiated
empirically. Of these patients, 47 had pulmonary
infiltrates on chest radiography and the other 26 had
symptoms of acute sinusitis or COPD. Commonly
used antibiotics included beta-lactams, quinolones,
and macrolides.
Outcome
Six patients (5.3%) were admitted to the ICU
because of acute respiratory failure and 4 of them
(3.5%) required mechanical ventilation. All these
6 patients were younger than 40 years old. Their
laboratory test results revealed leukopenia in 4
patients, thrombocytopenia in 3, hyperglycemias in 5,
elevated ALT/AST levels in 4, and elevated creatinine
levels in 2. The time from onset of symptoms to
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Table 4. Treatment and outcome of hospitalized patients with
confirmed 2009 influenza A(H1N1) virus infection.

Treatment and Outcome

No. (%) of Patients
(n = 113)

Oseltamivir treatment

98 (86.7)

Oseltamivir treatment received within
48 h of onset of symptoms

51 (45.1)

Antibiotic treatment

73 (64.6)

Intensive care unit admission

6 (5.3)

Required mechanical ventilation

4 (3.5)

Fatal cases

3 (2.7)

Median duration of hospitalization,
days

2 (1-27)

hospital admission was longer than 3 days in all
of them. An underlying medical condition was
detected in 2 patients (pregnancy and COPD). All of
these 6 patients received oseltamivir and antibiotic
treatment. Only 1 patient received oseltamivir within
48 h of the onset of symptoms.
Among 113 hospitalized patients with 2009
influenza A(H1N1) virus infection, 3 patients
(2.7%) died in the ICU. The patients died 6, 8, and
41 days after the onset of illness. The time periods
between the ICU admissions to death were 2, 4, and
27 days. The dead patients were younger than 40
years old (19, 27, and 39 years). None of them had
an underlying medical condition. All 3 patients who
died had thrombocytopenia, severe hypoxemia,
and pulmonary infiltrates on chest radiography on
admission. Two of them had leukopenia; their WBC
counts were 1300/mm3 and 1100/mm3. These nonsurviving patients developed ARDS and disseminated
intravascular coagulation (DIC) during their ICU
stay. All of the patients who died received oseltamivir
and antibiotics. None of them received oseltamivir
within 48 h of the onset of symptoms because of late
admission to hospital.
The surviving patients (110, 97.3%) were
discharged without any complication. The mean
duration of hospitalization for the surviving patients
was 2.9 ± 2.1 days.

Analysis of patients with pneumonia:
A comparison between the patients with and
without pneumonia was performed statistically
(Table 5). Age older than 40 years old, time from
onset of symptoms to admission longer than 3 days,
leukocytosis, ALT/AST elevation, and hyperglycemia
were significantly higher in patients with pneumonia.
Discussion
The age distribution of incidence of H1N1
influenza is different from that of seasonal influenza.
Young adults were the most affected people. Although
underlying medical conditions were common in the
hospitalized patients, severe illness was identified
among the young, healthy persons (6,8,9). In our
analysis, most of the patients, including those
admitted to the ICU, were under 40 years old. Other
reports with a large number of patients suggested
that although young people were the most affected,
mortality was higher in older ages (6-8,10).
Signs and symptoms of 2009 influenza A (H1N1)
virus infection are similar to those of seasonal
influenza. As reported in this paper, the typical
symptoms are fever, cough, sore throat, rhinorrhea,
myalgia, headache, and fatigue. Vomiting and
diarrhea were detected more commonly than in
seasonal influenza (6,7,10). In our series, vomiting
was reported in 26.5% of the patients, with diarrhea
in 8.8%.
In a pattern similar to that of seasonal influenza, a
large number of the hospitalized patients with H1N1
influenza had underlying medical conditions, and
chronic pulmonary diseases were the most common
condition (5,6,8,9). In this report, underlying medical
conditions were present in 56.6% of the patients, with
chronic pulmonary diseases ranking first (14.5%).
Pregnant women were the other important risk
group for severe H1N1 influenza (6-8,11,12). In this
case series, 25 of the patients were pregnant and 1 of
them was followed up in the ICU.
Our series showed that the pandemic H1N1
infection resulted in ICU admission in 5.3% of
hospitalized patients and death in 2.7%. A report
from the US suggested higher rates, stating that, from
272 hospitalized patients, 25% were admitted to the
ICU and 7% died. In that series, 45% percent of the

511

Influenza A(H1N1) in hospitalized patients

Table 5. Comparison of patients with and without pneumonia.

No. (%) of Patients
Characteristics

P value
with pneumonia
(n = 47)

without pneumonia
(n = 65)

Mean age
Age > 40 years

41.9 ± 17.1
23 (62.2)

31 ± 13.4
14 (37.8)

<0.001
0.004

Female gender

26 (36.1)

46 (63.9)

0.112

Underlying medical conditions

31 (49.2)

32 (50.8)

0.086

Time from symptom onset to admission

5.1 ± 3.8

2.9 ± 1.9

0.001

Time from onset to admission > 3 days

27 (54)

23 (46)

0.023

Leukopenia (WBC < 4400/mm3)

13 (52)

12 (48)

0.261

3

Leukocytosis (WBC > 11,300/mm )

9 (75)

3 (25)

0.027

25 (47.2)

28 (52.8)

0.340

3 (50)

3 (50)

0.697

Thrombocytopenia (<150,000/mm )

10 (65.5)

19 (34.5)

0.385

Elevation of ALT/AST (>45 U/L)

17 (65.4)

9 (34.6)

0.006

Neutrophilia (>74%)
Lymphocytosis (>45%)
3

Elevation of creatinine (>1.4 mg/dL)

4 (66.7)

2 (33.3)

0.398

Hyperglycemia (>115 mg/dL)

17 (70.8)

7 (29.2)

0.003

20 (40)

30 (60)

0.847

Oseltamivir < 48 h after symptom onset

patients were under the age of 18 years and 73% had
at least 1 underlying medical condition (6).
Pulmonary infection is the most frequent and
severe complication of influenza. On admission to our
hospital, all the patients underwent chest radiography.
Pulmonary infiltrates consistent with pneumonia
were detected in 41.6% of the patients. Similarly, other
series reported pulmonary infiltrates in the majority
of patients. The US series reported pulmonary
infection in 40% of hospitalized patients (6). In the
Australia and New Zealand series, viral pneumonia or
ARDS developed in 48.8% of critically ill patients and
secondary bacterial pneumonia in 20.3% (13).
Patients who were admitted to the ICU and who
died had shortness of breath, and radiographically
shown pneumonia and hypoxia. During ICU stay,
ARDS developed in the fatal cases. The other reports
also stated that patients who were admitted to the ICU
and who died were more likely to have pneumonia
and respiratory failure (7,6,9). Thus it can be
concluded that pulmonary status of the patient is an
important clue for the prognosis of H1N1 influenza.
512

While we detected WBC counts in the normal
range in most of the patients, neutrophilia and
lymphopenia were found in the majority. This is an
interesting finding. Lymphocytosis was expected
in a viral disease. Thrombocytopenia was another
important characteristic of the disease. In the US
case series, 20% of patients had leukopenia, 18% had
leukocytosis, and 14% had thrombocytopenia, which
is similar to our results (6).
Among the ICU-admitted 6 patients, 4 had
leukopenia and 3 had thrombocytopenia. Moreover,
all patients who died had thrombocytopenia and 2
had leukopenia. The numbers of these patients are
too small for a statistical comparison, but it seems
that leukopenia and thrombocytopenia are common
in severe cases. Thus, we considered that leukopenia
and thrombocytopenia might have a prognostic value
for 2009 influenza A (H1N1) infection.
We recommended antiviral treatment to all of the
patients on admission, including pregnant women, as
the CDC states (14). All the patients who were not
pregnant received antiviral treatment. Interestingly,
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more than half of the pregnant women did not accept
the antiviral treatment, although the risk of infection
in pregnancy and the safety of the drug for the fetus
were explained to them.
Data suggest that early antiviral treatment is
important for prognosis of the disease. In our series
none of the patients who died received oseltamivir
within 48 h of the onset of symptom and only 1
patient admitted to the ICU was started on early
treatment. In the US series none of the 19 nonsurviving patients received antiviral treatment within
48 h of the onset of symptoms (6). Delayed initiation
of antiviral treatment may contribute to an increased
severity of illness.
Blood cultures were done in the patients with
leukocytosis or pulmonary infiltration on chest
radiography. However, all the blood cultures were
negative. Thus, bacterial co-infections were not
detected in any patients. Some patients received
antibiotics before the culture collection, which could
have reduced the diagnostic sensitivity. Microbiologic
evidence of secondary bacterial infection is also
uncommon in other series. In the US series, only 3
of 182 patients had positive blood cultures (6). E.
coli (urosepsis), S. pneumoniae (pneumonia), and S.
aureus (pneumonia) were the growth bacteria. In the
California series, secondary bacterial infection was
identified in 4% of patients (7).
All the patients with pulmonary infiltration on
chest radiography received antibiotics. The same
approach is common in the literature. In other
series, 97%-98.8% of the patients with pulmonary

infiltration were given broad spectrum antibacterial
agents because of initial suspicion of bacterial
pneumonia (6,8). We could not confirm secondary
bacterial pneumonia with laboratory tests but we
considered the possibility of secondary bacterial
pneumonia clinically in the patients with pulmonary
infiltration and initiated antibiotic treatment
empirically. The risk of this approach is improper
use of antibiotics. However, it is reported that, in
the absence of accurate diagnostic methods, patients
who are hospitalized with suspected influenza and
pulmonary infiltrates on chest radiography should be
considered for treatment with both antibiotics and
antiviral drugs (6).
Age older than 40 years old, late admission,
leukocytosis, ALT/AST elevation, and hyperglycemia
were significantly more common in patients with
pneumonia. A higher rate of complications in older
patients is an expected finding. Hyperglycemia is
a known risk factor for complications and death.
Delayed admission was also associated with increased
risk of severity in other series. In a previous report,
the risk increased 1.19-fold per day (5). Leukocytosis
may be related to secondary pulmonary infection.
In conclusion, although the 2009 influenza
A(H1N1) virus causes severe illness including
pneumonia and death, the mortality rate is not very
high. The characteristics of the disease are similar to
those of seasonal influenza. Young adults were the
most affected persons and most of the patients had
underlying medical conditions.
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